AI designs antibiotics for gonorrhoea and MRSA superbugs
The drugs were designed atom-by-atom by the AI and killed the superbugs in laboratory and animal tests.
The two compounds still need years of refinement and clinical trials before they could be prescribed.
But the Massachusetts Institute of Technology (MIT) team behind it say AI could start a "second golden age" in antibiotic discovery.
Antibiotics kill bacteria, but infections that resist treatment are now causing more than a million deaths a year.
Overusing antibiotics has helped bacteria evolve to dodge the drugs' effects, and there has been a shortage of new antibiotics for decades.Researchers have previously used AI to trawl through thousands of known chemicals in an attempt to identify ones with potential to become new antibiotics.New superbug-killing antibiotic discovered using AINow, the MIT team have gone one step further by using generative AI to design antibiotics in the first place for the sexually transmitted infection gonorrhoea and for potentially-deadly MRSA (methicillin-resistant Staphylococcus aureus).Their study, published in the journal Cell, interrogated 36 million compounds including those that either do not exist or have not yet been discovered.Scientists trained the AI by giving it the chemical structure of known compounds alongside data on whether they slow the growth of different species of bacteria.The AI then learns how bacteria are affected by different molecular structures, built of atoms such as carbon, oxygen, hydrogen and nitrogen.Two approaches were then tried to design new antibiotics with AI. The first identified a promising starting point by searching through a library of millions of chemical fragments, eight to 19 atoms in size, and built from there. The second gave the AI free rein from the start.The design process also weeded out anything that looked too similar to current antibiotics. It also tried to ensure they were inventing medicines rather than soap and to filter out anything predicted to be toxic to humans.Scientists used AI to create antibiotics for gonorrhoea and MRSA, a type of bacteria that lives harmlessly on the skin but can cause a serious infection if it enters the body.Once manufactured, the leading designs were tested on bacteria in the lab and on infected mice, resulting in two new potential drugs."We're excited because we show that generative AI can be used to design completely new antibiotics," Prof James Collins, from MIT, tells the BBC."AI can enable us to come up with molecules, cheaply and quickly and in this way, expand our arsenal, and really give us a leg up in the battle of our wits against the genes of superbugs."However, they are not ready for clinical trials and the drugs will require refinement – estimated to take another one to two year's work – before the long process of testing them in people could begin.I found a bacteria-eating virus in my loo – could it save your life?Dr Andrew Edwards, from the Fleming Initiative and Imperial College London, said the work was "very significant" with "enormous potential" because it "demonstrates a novel approach to identifying new antibiotics".But he added: "While AI promises to dramatically improve drug discovery and development, we still need to do the hard yards when it comes to testing safety and efficacy."That can be a long and expensive process with no guarantee that the experimental medicines will be prescribed to patients at the end.Some are calling for AI drug discovery more broadly to improve. Prof Collins says "we need better models" that move beyond how well the drugs perform in the laboratory to ones that are a better predictor of their effectiveness in the body.There is also an issue with how challenging the AI-designs are to manufacture. Of the top 80 gonorrhoea treatments designed in theory, only two were synthesised to create medicines.Prof Chris Dowson, at the University of Warwick, said the study was "cool" and showed AI was a "significant step forward as a tool for antibiotic discovery to mitigate against the emergence of resistance".However, he explains, there is also an economic problem factoring into drug-resistant infections – "how do you make drugs that have no commercial value?"If a new antibiotic was invented, then ideally you would use it as little as possible to preserve its effectiveness, making it hard for anyone to turn a profit. – BBC
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
13 hours ago
- Arab News
Tech leaders should focus on job creation, not displacement
When ChatGPT stormed onto the scene in late 2022, the alarm bells rang loud. Philosophers and futurists demanded new rules to prevent humanity from sliding into chaos, wars and disorder. Since then, a string of large language models and apps — Gemini, Grok, Perplexity, Meta AI — have caused fresh anxieties. Two years on, true artificial general intelligence is still a distant goal but the mixed results of widespread adoption of AI are already plain to see. Change that was happening gradually is now happening swiftly. As veteran Wall Street Journal commentator Peggy Noonan wrote in a recent column, 'The story is no longer 'AI in coming decades will take a lot of jobs' or 'AI will take jobs sooner than we think.' It is 'AI is here and a quiet havoc has begun.' Yet, for America's AI titans, the motivation today seems less about building tools that create new jobs and more about accelerating human displacement while envisioning a vast social safety net as compensation. A recent article in the Wall Street Journal titled 'What Musk, Altman and Others Say About AI-Funded 'Universal Basic Income'' stated: 'Suddenly, an idea once seen as a socialist policy that would reward idleness is one of the AI boom's hottest acronyms.' According to the article, the consensus in Silicon Valley is that automation driven by AI is going to replace a lot of factory jobs and white-collar roles while generating billions in profits for AI companies. What tech leaders and gurus seem divided over is whether AI-funded universal basic income is the answer to the challenge of mass unemployment. Of course, as the popular 1956 Doris Day song 'Que Sera, Sera (Whatever Will Be, Will Be)' reminds us: 'The future's not ours to see … what will be, will be.' Perhaps there is no need to worry excessively, as many a bleak prophecy in the past (for example, 'The Population Bomb,' a book by Paul R. Ehrlich about the looming danger of overpopulation) failed to come to pass. High-quality jobs give young people a reason to get up in the morning, a sense of fulfillment and a feeling of progress in their lives. We risk losing the essence of this in an idle society with universal basic income. Arnab Neil Sengupta Perhaps the 'quiet havoc' of which Noonan spoke is a temporary phenomenon and US employment numbers will pick up, similar to the way in which the development of mainframe computers in the 1950s created entirely new occupations. In any case, AI tycoons such as Elon Musk, Sam Altman and Marc Benioff ought to be thinking of ways in which AI can be used to create plentiful, professionally rewarding jobs instead of touting the introduction of universal basic income as inevitable. Not only would such income for Americans made redundant by AI be of little use to the rest of the world, it could be a recipe for trouble in the long term. Jobs do not just pay wages, as the Silicon Valley titans surely know. Jobs circulate money throughout the economy, creating demand for goods and services, generating tax revenues and nurturing communities. A purely passive income scheme will not generate the same level of productive economic activity. For many people, especially young adults, meaningful work is a core part of their identity. For young people in the Arab world, it is not an exaggeration to say a job equals purpose, self-worth and hope. Employment in challenging roles builds skills, creativity and problem-solving capacities that are essential for adapting to future changes. High-quality jobs in particular give educated young people a sense of fulfillment and progress in their lives. This satisfaction would be at risk of being lost in an idle society. The workplace is a powerful training ground. Before the advent of remote working, conversation and competition made busy offices incubators of great ideas. In his memoir 'City Room,' Arthur Gelb, the late American journalist, described the New York Times newsroom of the 1940s this way: 'There was an overwhelming sense of purpose, fire and life: the clacking rhythm of typewriters, the throbbing of great machines in the composing room on the floor above, reporters shouting for copy boys to pick up their stories.' Employment creates networks, encourages teamwork and accountability, and strengthens civic engagement. On the other hand, large-scale joblessness, especially among young people, produces social drift, weakens bonds, increases division, feeds unrest and erodes hope. AI tycoons such as Elon Musk, Sam Altman and Marc Benioff ought to be thinking of ways in which AI can be used to generate plentiful, professionally rewarding jobs instead of touting the introduction of universal basic income as inevitable. Arnab Neil Sengupta No matter what term tech tycoons choose to apply to it — 'universal extreme wealth,' 'universal high income' or 'universal basic income' — the dangers of financially rewarding idleness can scarcely be overstated. In addition to the erosion of motivation and the work ethic, a guaranteed income without the expectation of contribution might lead to disconnection from skills-building and long-term planning. There is also the risk of social fragmentation and alienation. Without shared daily activities like work, people living off AI profits could become more isolated, lose touch with community norms, and fall into destructive habits or radicalized echo chambers. None of this is an argument for a Luddite agenda resisting the adoption of a technology whose time has come. Even California socialists do not advocate turning back the clock — although, ultimately, robots rather than American workers might end up doing the heavy lifting of President Trump's planned manufacturing renaissance. If the technological displacement of human workers proves unstoppable, the pace and scale of AI-driven automation will undoubtedly make job creation in some sectors unviable. A universal basic income could at least ensure that people's basic needs are met in a fully automated economy. A guaranteed supplemental income could also reduce some of the economic insecurity and stress. It could provide a safety net that allows people to take entrepreneurial risks, retrain or transition to new industries without fear of destitution, potentially prompting innovation from the ground up. In theory, the recipients of universal basic income would have the freedom to pursue non-market value creation. Thus, with their basic needs covered, people could focus on care-giving, volunteering, education, the creative arts or environmental projects that existing markets do not adequately reward, even though the wider society still benefits from them. If the pros and cons of an AI-funded 'universal high income' make it sound like a quixotic experiment in wealth generation — lowering costs for companies and then handing out part of the profits in a post-work future — that is because it indeed would be if tried. Job-loss fears are real, but the remedy should not be worse than the disease. Ultimately, the responsibility of tech leaders is not to make mass idleness the new normal, but to harness AI in ways that expand human opportunity. • Arnab Neil Sengupta is a senior editor at Arab News.
Asharq Al-Awsat
2 days ago
- Asharq Al-Awsat
Taiwan Raises 2025 GDP Growth Forecast to 4.45% on Strong Tech Exports
Taiwan's economy is expected to grow faster in 2025 than previously forecast, the statistics agency said on Friday, as the island continues to reap the benefits of strong demand for tech and artificial intelligence-related products. Taiwan's gross domestic product is now expected to expand 4.45% this year, according to the official forecast from the Directorate General of Budget, Accounting and Statistics, higher than the 3.1% it forecast in May. Exports this year from Taiwan, a major producer of chips powering the AI surge, are predicted to expand by 24.04%, the agency said, upgrading sharply a previous forecast of 8.99%. The optimistic outlook comes even after US President Donald Trump imposed a 20% tariff on Taiwan goods, Reuters reported. Taiwan's government has said the 20% tariff is "temporary" as it continues to negotiate with the US for more favorable rates. Gross domestic product expanded by a revised 8.01% in the second quarter from a year earlier, compared with a preliminary 7.96%, the statistics agency said. It also lowered the forecast for the consumer price index (CPI) to 1.76% from 1.88% previously.
Saudi Gazette
2 days ago
- Saudi Gazette
AI designs antibiotics for gonorrhoea and MRSA superbugs
NEW YORK – Artificial intelligence has invented two new potential antibiotics that could kill drug-resistant gonorrhoea and MRSA, researchers have revealed. The drugs were designed atom-by-atom by the AI and killed the superbugs in laboratory and animal tests. The two compounds still need years of refinement and clinical trials before they could be prescribed. But the Massachusetts Institute of Technology (MIT) team behind it say AI could start a "second golden age" in antibiotic discovery. Antibiotics kill bacteria, but infections that resist treatment are now causing more than a million deaths a year. Overusing antibiotics has helped bacteria evolve to dodge the drugs' effects, and there has been a shortage of new antibiotics for have previously used AI to trawl through thousands of known chemicals in an attempt to identify ones with potential to become new superbug-killing antibiotic discovered using AINow, the MIT team have gone one step further by using generative AI to design antibiotics in the first place for the sexually transmitted infection gonorrhoea and for potentially-deadly MRSA (methicillin-resistant Staphylococcus aureus).Their study, published in the journal Cell, interrogated 36 million compounds including those that either do not exist or have not yet been trained the AI by giving it the chemical structure of known compounds alongside data on whether they slow the growth of different species of AI then learns how bacteria are affected by different molecular structures, built of atoms such as carbon, oxygen, hydrogen and approaches were then tried to design new antibiotics with AI. The first identified a promising starting point by searching through a library of millions of chemical fragments, eight to 19 atoms in size, and built from there. The second gave the AI free rein from the design process also weeded out anything that looked too similar to current antibiotics. It also tried to ensure they were inventing medicines rather than soap and to filter out anything predicted to be toxic to used AI to create antibiotics for gonorrhoea and MRSA, a type of bacteria that lives harmlessly on the skin but can cause a serious infection if it enters the manufactured, the leading designs were tested on bacteria in the lab and on infected mice, resulting in two new potential drugs."We're excited because we show that generative AI can be used to design completely new antibiotics," Prof James Collins, from MIT, tells the BBC."AI can enable us to come up with molecules, cheaply and quickly and in this way, expand our arsenal, and really give us a leg up in the battle of our wits against the genes of superbugs."However, they are not ready for clinical trials and the drugs will require refinement – estimated to take another one to two year's work – before the long process of testing them in people could begin.I found a bacteria-eating virus in my loo – could it save your life?Dr Andrew Edwards, from the Fleming Initiative and Imperial College London, said the work was "very significant" with "enormous potential" because it "demonstrates a novel approach to identifying new antibiotics".But he added: "While AI promises to dramatically improve drug discovery and development, we still need to do the hard yards when it comes to testing safety and efficacy."That can be a long and expensive process with no guarantee that the experimental medicines will be prescribed to patients at the are calling for AI drug discovery more broadly to improve. Prof Collins says "we need better models" that move beyond how well the drugs perform in the laboratory to ones that are a better predictor of their effectiveness in the is also an issue with how challenging the AI-designs are to manufacture. Of the top 80 gonorrhoea treatments designed in theory, only two were synthesised to create Chris Dowson, at the University of Warwick, said the study was "cool" and showed AI was a "significant step forward as a tool for antibiotic discovery to mitigate against the emergence of resistance".However, he explains, there is also an economic problem factoring into drug-resistant infections – "how do you make drugs that have no commercial value?"If a new antibiotic was invented, then ideally you would use it as little as possible to preserve its effectiveness, making it hard for anyone to turn a profit. – BBC
